InvestorsHub Logo
Followers 376
Posts 17216
Boards Moderated 3
Alias Born 03/07/2014

Re: None

Friday, 05/08/2015 11:38:52 AM

Friday, May 08, 2015 11:38:52 AM

Post# of 92948
LOL BS quote: "Another message/board OCAT post is getting attention.

OCATA Therapeutics PPS projections based on TOTAL ADDRESSABLE MARKET(TAM) for Pivotal SMD and Phase 2 AMD and upcoming milestones 2015/2016 (LOL what imaginary "market" when they HAVE NO PRODUCTS TO EVEN SELL YET???)

2nd quarter 2015: $35.00 plus (NOT A CHANCE, NO. Sitting at a SOLID $6 and small change in MID MAY 2015)
Based on upcoming OCAT Milestones in Q2: (it's MID MAY, and NO)
1. SMD granted SPA by USFDA. (NO, MID MAY not happening yet)
2. First SMD patient treated in Pivotal Trial. (NOT happened yet)
3. First AMD patient treated in phase 2 Trial. (NO, NOT YET)
4. Asian patients Data published. (Yep, and market panned it)
5. Phase 1 complete data set released of all 38 patient AMD trial. (Market panned)
6. JV Non core assets. (NOPE, and not even a mention in CC or 10-Q)
7. Data published for Tuft's dog trials based on OCAT cell therapies for Lupus, Chron's etc. (NOPE, not a happening so far, "articles" being published have been a goose egg for this company anyway. WHERE'S THE MONEY??)
8. IND filed with FDA for RPC's to cure blindness even in patients with dead rods and cones. (NOPE, nothing on that one either)
9. Multiple additional sites for both here and EU for both SMD and AMD trials. (It can be 1000 "sites" but with NO MONEY TO FUND IT, what difference does it make anyway??)

3rd quarter 2015: $70.00 plus (LOL, LOL oh wow !!)
1. EU Pivotal Trial SMD Therapy partnership with major EU Big PHARMA. (NOT A CHANCE IMO. Too funny)
2. US partnership for AMD therapy. (NOT A CHANCE IMO, too funny)
3. MS mice data published in peer review Journal. (MICE? Means 15 yrs minimum and $100's of millions to even a remote chance at a product - what difference would it make? They can't even fund or raise serious cash for what they have now???)

4th quarter 2015: $ 100.00+ (BEYOND LAUGHABLE !!! Never gonna happen IMO. Not in 2015, not ever)
1. EU halts orphan SMD pivotal trial and grants OCAT marketing authorization for all of EU based on overwhelming safety and efficacy. (NOPE, just more myths and conjecture DREAMING)
2. US FDA halts orphan SPA SMD therapy and grants approval based on overwhelming safety and efficacy. (LOL, NO. The FDA doesn't do that)
3. FDA grants breakthrough designation for OCAT AMD therapy. (LOL, I wouldn't even give that Vegas craps table odds)
4. Dr. Lanza and Dr. Langer receive Nobel. (Good luck)

Considering the little "micro blog" source of all those vast "predictions" and its track record for being dead wrong in the vast "prediction department" (for YEARS)- not a chance at even remotely coming true as stated IMO. Not even close. Past Vegas or lotto odds IMO.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.